Guangzhou Baiyunshan Hutchison Whampoa Chinese Medicine Co., Ltd.

Guangzhou Baiyunshan Hutchison Whampoa Chinese Medicine Co., Ltd. (abbreviated as "Baiyunshan Hutchison Chinese Medicine") was jointly established in May 2005 by Guangzhou Pharmaceutical Group and Hutchison Whampoa (China) Company. With a registered capital of RMB 200 million, the company has 11 wholly-owned and holding subsidiaries, covering business segments such as the production, manufacturing, and distribution of pharmaceuticals and health products, cultural tourism and health care, and herbal medicine cultivation. Baiyunshan Hutchison Chinese Medicine currently has 9 dosage forms including tablets and granules, with 147 product approvals. It possesses 8 exclusive varieties, 10 high-tech products of Guangdong Province, and 5 famous brand products of Guangdong Province. Main products include: Banlangen Granules, Compound Danshen Tablets, Kouyanqing Granules, Naoxin Qing Tablets, Xiaoyan Lidan Tablets, Ganmaoling Granules, Chuanxinlian Tablets, Danhong Huayu Oral Liquid, etc. The company has successively received honors such as National High-tech Enterprise, National Innovative Pilot Enterprise, National Advanced Grassroots Party Organization, National May Day Labor Award, National Science and Technology Progress Second Prize, and China Patent Excellence Award. Baiyunshan Hutchison Chinese Medicine adheres to the ten-character policy of "Education, Love, Technology, Innovation, and Responsibility," promoting the technological, digital, international, and modern development of the traditional Chinese medicine (TCM) health industry. Centering on economic benefits, the company strengthens internal management, expands external markets, and implements three major strategies: "Talent, Brand, and Technology." It has built five core competitive advantages: Party building pioneer, talent project, technological innovation, cultural heritage, and responsible marketing. Baiyunshan Hutchison Chinese Medicine has established the first corporate modern Chinese medicine research institute in South China. By integrating external advantageous technological resources, it strives to improve the construction of national, provincial, and municipal technological innovation platforms, and vigorously strengthens the development of core technology and independent innovation capabilities. The company has a post-doctoral research station, a key laboratory of Guangdong Province, a Guangdong science and technology expert workstation, and provincial and municipal engineering centers. It has built the largest GAP herbal medicine base for Banlangen in China, as well as GAP bases for Chuanxinlian, Danshen, and Xihuangcao, and has passed the national GAP base certification first in the industry. Baiyunshan Hutchison Chinese Medicine has invested heavily to build a national science education base, a TCM education base of the State Administration of Traditional Chinese Medicine, a national AAAA scenic area, and the first semi-open TCM museum integrating "nature" and "culture" - the "Shennong Grass Pavilion". It has received over 3.4 million domestic and international visitors, becoming a model of TCM cultural dissemination that appeals to both refined and popular tastes. Adhering to the social purpose of "Love Baiyunshan," Baiyunshan Hutchison Chinese Medicine bravely assumes social responsibility and strives to be the best corporate citizen. The company has established a "five-level quality control system" and pioneered the "household expired drug recall (free replacement) mechanism" worldwide, providing free replacement of expired drugs for consumers. Currently, the inheritance, innovation, and development of TCM are facing a major strategic opportunity period. New quality productive forces provide scientific guidance for accelerating technological innovation on the new journey and promoting the high-quality development of TCM. The company will consolidate its foundation, accelerate transformation and upgrading, and make comprehensive efforts to build itself into a leading enterprise in the modern TCM industry.